Literature DB >> 24953847

Relapse and its remission in Japanese patients with idiopathic membranous nephropathy.

Shinji Kitajima1, Kengo Furuichi, Norihiko Sakai, Akihiro Sagara, Yasuyuki Shinozaki, Tadashi Toyama, Yasunori Iwata, Miho Shimizu, Hitoshi Yokoyama, Shuichi Kaneko, Takashi Wada.   

Abstract

BACKGROUND: The prognosis in patients with idiopathic membranous nephropathy (IMN) is diverse. However, the prognosis after relapse and factors affecting relapse remain unclear.
METHODS: A total of 146 Japanese patients with IMN who had been followed up for at least 3 years, or until end-stage renal failure or death were enrolled in this retrospective study. The initial clinicopathological factors were examined between the patients with and without relapse. The patients were assigned to two groups based on the electron microscopic findings: homogeneous type with synchronous electron-dense deposits and heterogeneous type with various phases of dense deposits.
RESULTS: A total of 105 of the 146 patients (72 %) achieved complete remission (CR) or incomplete remission (ICR) I after initial treatment. Twenty-six of the 105 patients relapsed after CR or ICR I (25 %). There were no differences in initial clinical findings or data between the patients with and without relapse, except for the higher degree of proteinuria at onset in patients with relapse. The relapse rate of the heterogeneous group (43 %) was higher than that in the homogeneous group (20 %). There were no significant associations between relapse rate and immunosuppressive therapy at onset. Eleven of 26 patients showing relapse (42 %) achieved CR or ICR I, which was lower than the rate for patients with initial remission.
CONCLUSION: Our results suggest that patients with relapse achieved CR or ICR I and that electron microscopic findings demonstrating heterogeneous type indicated susceptibility to relapse.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24953847     DOI: 10.1007/s10157-014-0987-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  18 in total

1.  Membranous nephropathy--still a treatment dilemma.

Authors:  J S Cameron
Journal:  N Engl J Med       Date:  1992-08-27       Impact factor: 91.245

2.  The evolution of membranous glomerulonephritis reconsidered: new insights from a study on relapsing disease.

Authors:  T Törnroth; E Honkanen; E Pettersson
Journal:  Clin Nephrol       Date:  1987-09       Impact factor: 0.975

3.  Analysis of prognostic predictors in idiopathic membranous nephropathy.

Authors:  Q Wu; K Jinde; M Nishina; R Tanabe; M Endoh; Y Okada; H Sakai; K Kurokawa
Journal:  Am J Kidney Dis       Date:  2001-02       Impact factor: 8.860

4.  Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.

Authors:  B J Laluck; D C Cattran
Journal:  Am J Kidney Dis       Date:  1999-06       Impact factor: 8.860

5.  Focal glomerulosclerosis in idiopathic membranous glomerulonephritis.

Authors:  S Wakai; A B Magil
Journal:  Kidney Int       Date:  1992-02       Impact factor: 10.612

6.  Prognosis of idiopathic membranous nephropathy: a methodologic meta-analysis.

Authors:  B E Marx; M Marx
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

7.  The short- and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy. Kanazawa Study Group for Renal Diseases and Hypertension.

Authors:  H Yokoyama; S Goshima; T Wada; M Takaeda; K Furuichi; K Kobayashi; H Kida
Journal:  Nephrol Dial Transplant       Date:  1999-10       Impact factor: 5.992

8.  Treatment of idiopathic membranous nephropathy.

Authors:  T Ehrenreich; J G Porush; J Churg; L Garfinkel; S Glabman; M H Goldstein; E Grishman; S L Yunis
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

9.  Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy.

Authors:  Keiichi Yoshimoto; Hitoshi Yokoyama; Takashi Wada; Kengo Furuichi; Norihiko Sakai; Yasunori Iwata; Satoshi Goshima; Hiroshi Kida
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

10.  Long-term prognosis of membranous nephropathy.

Authors:  H Kida; T Asamoto; H Yokoyama; N Tomosugi; N Hattori
Journal:  Clin Nephrol       Date:  1986-02       Impact factor: 0.975

View more
  3 in total

1.  Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis.

Authors:  Kiyoki Kitagawa; Kengo Furuichi; Akihiro Sagara; Yasuyuki Shinozaki; Shinji Kitajima; Tadashi Toyama; Akinori Hara; Yasunori Iwata; Norihiko Sakai; Miho Shimizu; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2015-11-20       Impact factor: 2.801

2.  Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy.

Authors:  Shin'ichi Akiyama; Mari Akiyama; Enyu Imai; Takenori Ozaki; Seiichi Matsuo; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2014-11-21       Impact factor: 2.801

3.  A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades.

Authors:  Joshua Storrar; Tarra Gill-Taylor; Rajkumar Chinnadurai; Constantina Chrysochou; Dimitrios Poulikakos; Francesco Rainone; James Ritchie; Elizabeth Lamerton; Philip A Kalra; Smeeta Sinha
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.